Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
50 hedge funds and large institutions have $100M invested in Intersect ENT, Inc in 2014 Q3 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
+$16.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.1M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$5.75M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.32M |
| 5 |
AC
Aisling Capital
New York
|
+$5.27M |
Top Sellers
XENT Hedge Fund Activity: Q3 2014 in Review
50 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2014, worth a combined $100M.
Buyers outnumbered sellers: 50 funds opened new XENT positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Norwest Venture Partners XI, opening a new position worth an estimated $16.9M.
- 50 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $100M of Intersect ENT, Inc stock for Q3 2014.
- 50 funds opened new Intersect ENT, Inc positions in Q3 2014 and 0 closed out, a net change of +50 holders.
- The largest Intersect ENT, Inc buyer in Q3 2014 was Norwest Venture Partners XI, an estimated $16.9M added.
Based on aggregated 13F filings for Q3 2014.